Press Release
Apr 29, 2024
Cytiva has completed its integration of the Precision NanoSystems business
Newsroom
Read our latest press releases, learn about new products, for media inquiries contact media@precision-nano.com
LATEST NEWS
PRESS RELEASES
-
Press Release
Jul 13, 2023
Cytiva, a global life sciences leader, has launched the NanoAssemblr commercial formulation system, purpose-built for clinical and commercial manufacturing of lipid nanoparticle medicines. Fully compliant and offering automated instrumentation, the NanoAssemblr commercial formula...Read More -
Press Release
May 01, 2023
Fargo, North Dakota and Vancouver, British Columbia/PR/Newswire/May 1, 2023 -- Aldevron, a leading global manufacturer of DNA, RNA and proteins used in cell and gene therapies and vaccine development, will expand its mRNA production capabilities to include lipid nanoparticle (LNP...Read More -
Press Release
Jul 26, 2022
SAN DIEGO, Calif., and Vancouver, British Columbia/PR Newswire/July 26, 2022 --In a move that signifies the heightened focus on mRNA as a key tool in human health, Precision NanoSystems (PNI) and Replicate Bioscience will enter a licensing agreement to accelerate the creation, sc...Read More -
Press Release
Jun 13, 2022
Global leader in non-viral delivery of genomic medicines, Precision NanoSystems (PNI), entered into a strategic collaboration agreement with Aurora Vaccines to accelerate the development and manufacture of its Hepatitis C vaccine candidate. PNI will share its expertise in the dev...Read More -
Press Release
May 09, 2022
Vancouver, British Columbia, May 9, 2022 – Precision NanoSystems has launched a new off-the-shelf lipid nanoparticle (LNP) reagent mix called Read More
Press Release
Aug 11, 2021
Vancouver, British Columbia – August 11, 2021 - Precision NanoSystems (PNI), a global leader in innovative solutions for genetic medicine development, will expand its global headquarters with a 75,000-square-foot facility currently under construction. Slate...Read MoreIN THE NEWS
-
News Article
Jul 05, 2023
July 5, 2023 — We’ve updated our privacy policy. Read More about the latest privacy updates. PNI Privacy Policy UpdateRead More -
News Article
Mar 16, 2020
The NIH and Moderna have begun phase 1 clinical trials for a vaccine to protect against COVID-19. The vaccine, called mRNA-1273, is an advanced mRNA vaccine that utilizes genetic material to immunize patients. Moderna and the NIH were able to bring mRNA-1273 to clinical trials wi...Read More -
News Article
Jul 30, 2018
Read MorePrecision Nanosystems' Nanoassemblr technology uses microfluid continuous flow to control variables in the assembly of the nanoparticles. The company has three machines available that can scale depending on which stage of discovery a compound is in...
-
News Article
Apr 20, 2018
Read MoreTwo Vancouver-based companies are creating industry leading research tools and technology and helping B.C. stake its claim as a world-class burgeoning biotech hub. Precision NanoSystems Inc. (PNI) and Stemcell Technologies Inc. are just two of a gr...
-
News Article
Dec 20, 2017
Read MorePrecision NanoSystems is one of the fastest growing businesses in British Columbia (BC) according to the recently published Top 100 fastest-growing companies in BC list from business news journalBusiness in Vancouver&nbs...
-
News Article
Nov 23, 2017
Read MoreJoin Precision NanoSystems for a roundtable discussion on nanomedicines as part of the 3rd International Electronic Conference on Medicinal Chemistry. Organised by Pharmaceuticals journal, this free online conference runs until November 30th, and d...
Sign Up and Stay Informed
Sign up today to automatically receive new Cytiva, formerly Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.